Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shuiping Zhao & Daoquan Peng. (2018) Efficacy and safety of rosuvastatin versus atorvastatin in high-risk Chinese patients with hypercholesterolemia: a randomized, double-blind, active-controlled study. Current Medical Research and Opinion 34:2, pages 227-235.
Read now
Read now
Vivencio Barrios, José M. Lobos, Adalberto Serrano, Max Brosa, Margarita Capel & Concha Álvarez Sanz. (2012) Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain. Journal of Medical Economics 15:sup1, pages 45-54.
Read now
Read now
Vivencio Barrios & Carlos Escobar. (2009) Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA. Expert Review of Cardiovascular Therapy 7:11, pages 1317-1327.
Read now
Read now
Navin K Kapur & Kiran Musunuru. (2008) Clinical efficacy and safety of statins in managing cardiovascular risk. Vascular Health and Risk Management 4:2, pages 341-353.
Read now
Read now
Handrean Soran & Paul Durrington. (2008) Rosuvastatin: efficacy, safety and clinical effectiveness. Expert Opinion on Pharmacotherapy 9:12, pages 2145-2160.
Read now
Read now
Carolyn R Harley, Sanjay K Gandhi, Herbert Heien, Ken McDonough & Stephanie P Nelson. (2008) Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opinion on Pharmacotherapy 9:5, pages 669-676.
Read now
Read now
John R Crouse$suffix/text()$suffix/text(). (2008) An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability. Expert Opinion on Drug Metabolism & Toxicology 4:3, pages 287-304.
Read now
Read now
Jaakko Tuomilehto. (2007) Rosuvastatin: The Most Efficient Treatment Option For Patients With Dyslipidemia. Future Lipidology 2:2, pages 127-141.
Read now
Read now
Navin K Kapur. (2007) Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease. Expert Review of Cardiovascular Therapy 5:2, pages 161-175.
Read now
Read now
Articles from other publishers (12)
E. V. Sayutina, M. M. Shamuilova, L. I. Butorova, E. M. Tuayeva & A. L. Vertkin. (2020) Statin therapy in patients with high and very high cardiovascular risk: an optimal approach. Cardiovascular Therapy and Prevention 19:5, pages 2696.
Crossref
Crossref
O. N. Tkacheva, Yu. N. Belenkov, Yu. A. Karpov & S. K. Zyryanov. (2019) Gerontology Issues in Cardiology Practice. Kardiologiia 59:12, pages 54-63.
Crossref
Crossref
I. A. Alekseeva, T. E. Kolmakova & M. B. Ezhov. (2019) Fixeddose combination of rosuvastatin + ezetimibe: ease of use, safety and efficacy. Medical Council:16, pages 21-26.
Crossref
Crossref
К. G. Pereverzeva & S. S. Yakushin. (2019) Aspirin and statins: possibilities for joint improvement of prognosis in cardiovascular disease. Medical Council:21, pages 28-33.
Crossref
Crossref
A. E. Semenova & I. V. Sergienko. (2018) ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION. Eurasian heart journal:2, pages 28-41.
Crossref
Crossref
Inyoung HwangSang-In ParkSeungHwan LeeBackHwan LeeKyung-Sang YuJi-Young JeonMin-Gul Kim. (2018) Pharmacokinetics of fixed-dose combination of rosuvastatin 20 mg and ezetimibe 10 mg compared to concurrent administration of individual tablets in healthy Korean subjects. Translational and Clinical Pharmacology 26:1, pages 16.
Crossref
Crossref
N.S. Hari Narayana Moorthy, Nuno M.F.S.A. Cerqueira, Maria J. Ramos & Pedro A. Fernandes. (2015) Ligand based analysis on HMG-CoA reductase inhibitors. Chemometrics and Intelligent Laboratory Systems 140, pages 102-116.
Crossref
Crossref
Fabrizio Montecucco & François Mach. (2009) Update on statin-mediated anti-inflammatory activities in atherosclerosis. Seminars in Immunopathology 31:1, pages 127-142.
Crossref
Crossref
Katsumi Miyauchi, Norihide Takaya, Takahisa Hirose, Fuki Ikeda, Ryuzo Kawamori, Hidenori Ohishi, Kensaku Yoshida, Munetaka Yamamoto, Hajime Arai, Takao Urabe, Nobutaka Hattori, Michimasa Suzuki, Tadayuki Maehara, Kazuhiro Sase, Thomas S. Hatsukami, Chun Yuan & Hiroyuki Daida. (2009) Rationale and Design of the Carotid Plaque in Human for All Evaluations With Aggressive Rosuvastatin Therapy (CHALLENGER Trial) Evaluation by Magnetic Resonance Imaging. Circulation Journal 73:1, pages 111-115.
Crossref
Crossref
ANTONIO M. GOTTOJr.Jr. & LIONEL H. OPIE. 2009. Drugs for the Heart. Drugs for the Heart
341
372
.
Michael S. Kostapanos, Haralampos J. Milionis & Moses S. Elisaf. (2008) An Overview of the Extra-Lipid Effects of Rosuvastatin. Journal of Cardiovascular Pharmacology and Therapeutics 13:3, pages 157-174.
Crossref
Crossref
Rajiv Agarwal. (2007) Effects of Statins on Renal Function. Mayo Clinic Proceedings 82:11, pages 1381-1390.
Crossref
Crossref